Purple Biotech (PPBT) Short-Term Debt issuances (2014 - 2026)

Purple Biotech (PPBT) has reported Short-Term Debt issuances for 8 consecutive years, with $2000.0 the latest figure, recorded in Q1 2026.

• On a quarterly basis, Short-Term Debt issuances changed 0.0% year-over-year to $2000.0 in Q1 2026; TTM through Mar 2026 was $1000.0, a 114.29% increase from a year earlier, with the FY2024 full-year figure at $2000.0, down 99.99% from the prior year.
• Short-Term Debt issuances was $2000.0 for Q1 2026 at Purple Biotech, roughly flat from $2000.0 in the prior quarter.
• Over five years, Short-Term Debt issuances peaked at $20.3 million in Q1 2022 and troughed at -$6.0 million in Q2 2022.
• A 5-year average of $3.3 million and a median of $2000.0 in 2025 frame the typical range for Short-Term Debt issuances.
• Across the five-year window, Short-Term Debt issuances jumped 100.05% in 2023 and sank 200.0% in 2024, its largest moves.
• Over 5 years, Short-Term Debt issuances stood at -$6.0 million in 2022, then soared by 99.9% to -$6000.0 in 2023, then surged by 50.0% to -$3000.0 in 2024, then soared by 166.67% to $2000.0 in 2025, then changed by 0.0% to $2000.0 in 2026.
• The last three Short-Term Debt issuances figures came in at $2000.0 (Q1 2026), $2000.0 (Q1 2025), and -$3000.0 (Q3 2024), per Business Quant data.